基替代的 siderophore colistin 显示出比其未经修改的多类对应物更高的抗菌活性
Sara Bescós-Ramo1,2, Enrique Gámez3,4, María Del Mar Encabo-Berzosa5
1Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Zaragoza, 50009, Spain.
BMC chemistry
|June 9, 2025
概括
研究人员通过添加甲基醇组来修改抗生素胆固醇,显著提高其对大肠杆菌 (大肠杆菌) 的有效性. 这种新的方法显示了降低毒性和打击抗生素耐药性的潜力.
科学领域:
- 药用化学 医学化学
- 抗菌药物开发 抗菌药物开发
- 分子生物学分子生物学
背景情况:
- 胆固醇是一种最后的抗生素,面临着耐药性和毒性挑战.
- 塞菲德罗科尔是一种,由于其由甲基醇替代的 siderophore 结构,显示出强大的抗菌活性.
研究的目的:
- 通过结合甲基醇部分来增强素的抗菌疗效和安全性.
- 研究catechol修饰对对抗致病细菌,特别是大肠杆菌的素活性的影响.
主要方法:
- 通过化和化,醇部分与素的共价合.
- 对抗尿病原性大肠杆菌的临床菌株的最小抑制度 (MIC) 和最小杀菌度 (MBC) 的评估.
- 细胞毒性评估使用人类纤维细胞,角质细胞和人类器官的3D模型.
主要成果:
- 化策略的catechol合并减少了MIC对浮游生物大肠杆菌50%和MBC25%.
- 修改后的胆固醇在杀菌剂量下对人类皮肤细胞 (纤维细胞和角质细胞) 没有表现出细胞毒性.
- 在测试剂量的人类器官中没有观察到细胞毒性,解决了素的潜在毒性.
结论:
- 胆固醇用甲基组的化学修饰增强了其抗微生物功效,并降低了所需剂量.
- 这种用甲基醇替代的胆固醇表现出改善的安全性,在相关的人类细胞模型中没有观察到细胞毒性.
- 将甲基醇组纳入现有抗生素的战略为开发下一代抗微生物药物提供了一个有希望的途径,其耐药性发展潜力降低.
相关概念视频
Antimicrobial Proteins
945
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
945
Antibiotic Selection
52.4K
Overview
52.4K
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K


